Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in PLoS Biol Retrieve available abstracts of 42 articles: HTML format

Single Articles

August 2021
1. WANG SY, Takahashi T, Pine AB, Damsky WE, et al
   Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
   PLoS Biol. 2021;19:e3001373.
   PubMed     Abstract available
   
   
   July 2021
2. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
   Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
   PLoS Biol. 2021;19:e3001333.
   PubMed     Abstract available
   
   
   
3. HOTEZ PJ
   Mounting antiscience aggression in the United States.
   PLoS Biol. 2021;19:e3001369.
   PubMed     Abstract available
   
   
   June 2021
4. HEFFRON AS, McIlwain SJ, Amjadi MF, Baker DA, et al
   The landscape of antibody binding in SARS-CoV-2 infection.
   PLoS Biol. 2021;19:e3001265.
   PubMed     Abstract available
   
   
   
5. NICHOLS JD, Bogich TL, Howerton E, Bjornstad ON, et al
   Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.
   PLoS Biol. 2021;19:e3001307.
   PubMed     Abstract available
   
   
   May 2021
6. VOGELS CBF, Breban MI, Ott IM, Alpert T, et al
   Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
   PLoS Biol. 2021;19:e3001236.
   PubMed     Abstract available
   
   
   
7. FU D, Zhang G, Wang Y, Zhang Z, et al
   Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
   PLoS Biol. 2021;19:e3001209.
   PubMed     Abstract available
   
   
   April 2021
8. MOGHADAS SM, Vilches TN, Zhang K, Nourbakhsh S, et al
   Evaluation of COVID-19 vaccination strategies with a delayed second dose.
   PLoS Biol. 2021;19:e3001211.
   PubMed     Abstract available
   
   
   
9. FRASER N, Brierley L, Dey G, Polka JK, et al
   The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
   PLoS Biol. 2021;19:e3000959.
   PubMed     Abstract available
   
   
   
10. GALLAGHER T, McCray PB Jr
    The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
    PLoS Biol. 2021;19:e3001217.
    PubMed     Abstract available
    
    
    
11. ZHU X, Mannar D, Srivastava SS, Berezuk AM, et al
    Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    PLoS Biol. 2021;19:e3001237.
    PubMed     Abstract available
    
    
    
12. FERGUSON J, Dunn S, Best A, Mirza J, et al
    Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
    PLoS Biol. 2021;19:e3001216.
    PubMed     Abstract available
    
    
    March 2021
13. REVERBY SM
    Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines.
    PLoS Biol. 2021;19:e3001167.
    PubMed     Abstract available
    
    
    
14. FULWEILER RW, Davies SW, Biddle JF, Burgin AJ, et al
    Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond.
    PLoS Biol. 2021;19:e3001100.
    PubMed     Abstract available
    
    
    
15. KIM KS, Ejima K, Iwanami S, Fujita Y, et al
    A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001128.
    PubMed     Abstract available
    
    
    
16. MACLEAN OA, Lytras S, Weaver S, Singer JB, et al
    Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
    PLoS Biol. 2021;19:e3001115.
    PubMed     Abstract available
    
    
    
17. POHL MO, Busnadiego I, Kufner V, Glas I, et al
    SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    PLoS Biol. 2021;19:e3001006.
    PubMed     Abstract available
    
    
    
18. RAVINDRA NG, Alfajaro MM, Gasque V, Huston NC, et al
    Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    PLoS Biol. 2021;19:e3001143.
    PubMed     Abstract available
    
    
    February 2021
19. RIHN SJ, Merits A, Bakshi S, Turnbull ML, et al
    A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
    PLoS Biol. 2021;19:e3001091.
    PubMed     Abstract available
    
    
    
20. COMER SP, Cullivan S, Szklanna PB, Weiss L, et al
    COVID-19 induces a hyperactive phenotype in circulating platelets.
    PLoS Biol. 2021;19:e3001109.
    PubMed     Abstract available
    
    
    January 2021
21. HOTEZ PJ
    Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine.
    PLoS Biol. 2021;19:e3001068.
    PubMed     Abstract available
    
    
    December 2020
22. KIM JI, Park S, Bae JY, Lee S, et al
    Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    PLoS Biol. 2020;18:e3001024.
    PubMed     Abstract available
    
    
    
23. REIJNS MAM, Thompson L, Acosta JC, Black HA, et al
    A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection.
    PLoS Biol. 2020;18:e3001030.
    PubMed     Abstract available
    
    
    November 2020
24. KENNEDY DA, Read AF
    Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    PLoS Biol. 2020;18:e3001000.
    PubMed     Abstract available
    
    
    
25. ALTHOUSE BM, Wenger EA, Miller JC, Scarpino SV, et al
    Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control.
    PLoS Biol. 2020;18:e3000897.
    PubMed     Abstract available
    
    
    
26. ZHOU Y, Hou Y, Shen J, Mehra R, et al
    A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    PLoS Biol. 2020;18:e3000970.
    PubMed     Abstract available
    
    
    
27. KADING RC, Kingston T
    Common ground: The foundation of interdisciplinary research on bat disease emergence.
    PLoS Biol. 2020;18:e3000947.
    PubMed     Abstract available
    
    
    October 2020
28. KUDO E, Israelow B, Vogels CBF, Lu P, et al
    Detection of SARS-CoV-2 RNA by multiplex RT-qPCR.
    PLoS Biol. 2020;18:e3000867.
    PubMed     Abstract available
    
    
    
29. BRUCE EA, Huang ML, Perchetti GA, Tighe S, et al
    Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step.
    PLoS Biol. 2020;18:e3000896.
    PubMed     Abstract available
    
    
    
30. KUCHARSKI AJ, Funk S, Eggo RM
    The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science.
    PLoS Biol. 2020;18:e3000913.
    PubMed     Abstract available
    
    
    September 2020
31. SELZER L, Su Z, Pintilie GD, Chiu W, et al
    Full-length three-dimensional structure of the influenza A virus M1 protein and its organization into a matrix layer.
    PLoS Biol. 2020;18:e3000827.
    PubMed     Abstract available
    
    
    
32. LIEBERMAN NAP, Peddu V, Xie H, Shrestha L, et al
    In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
    PLoS Biol. 2020;18:e3000849.
    PubMed     Abstract available
    
    
    August 2020
33. KALINICH CC, Jensen CG, Neugebauer P, Petrone ME, et al
    Real-time public health communication of local SARS-CoV-2 genomic epidemiology.
    PLoS Biol. 2020;18:e3000869.
    PubMed     Abstract available
    
    
    
34. GOODSELL DS, Voigt M, Zardecki C, Burley SK, et al
    Integrative illustration for coronavirus outreach.
    PLoS Biol. 2020;18:e3000815.
    PubMed     Abstract available
    
    
    
35. COYNE C, Ballard JD, Blader IJ
    Recommendations for future university pandemic responses: What the first COVID-19 shutdown taught us.
    PLoS Biol. 2020;18:e3000889.
    PubMed     Abstract available
    
    
    June 2020
36. SNIJDER EJ, Limpens RWAL, de Wilde AH, de Jong AWM, et al
    A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.
    PLoS Biol. 2020;18:e3000715.
    PubMed     Abstract available
    
    
    April 2020
37. MAIA CHAGAS A, Molloy JC, Prieto-Godino LL, Baden T, et al
    Leveraging open hardware to alleviate the burden of COVID-19 on global health systems.
    PLoS Biol. 2020;18:e3000730.
    PubMed     Abstract available
    
    
    June 2019
38. ABDELNABI R, Geraets JA, Ma Y, Mirabelli C, et al
    A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
    PLoS Biol. 2019;17:e3000281.
    PubMed     Abstract available
    
    
    May 2019
39. PALLIKKUTH S, de Armas LR, Rinaldi S, George VK, et al
    Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.
    PLoS Biol. 2019;17:e3000257.
    PubMed     Abstract available
    
    
    February 2019
40. TURNER HL, Pallesen J, Lang S, Bangaru S, et al
    Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains.
    PLoS Biol. 2019;17:e3000139.
    PubMed     Abstract available
    
    
    September 2018
41. PHILLIPS AM, Ponomarenko AI, Chen K, Ashenberg O, et al
    Destabilized adaptive influenza variants critical for innate immune system escape are potentiated by host chaperones.
    PLoS Biol. 2018;16:e3000008.
    PubMed     Abstract available
    
    
    August 2018
42. KUCHARSKI AJ, Lessler J, Cummings DAT, Riley S, et al
    Timescales of influenza A/H3N2 antibody dynamics.
    PLoS Biol. 2018;16:e2004974.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: